Description
一站式的移动医疗医患服务平台
应用介绍：
导医通志在患者、医院、医生之间建立起一个一站式的移动医疗医患服务平台。用移动互联网的创新服务模式
来革新传统医疗的服务模式，优化医疗服务流程，通过移动互联网来大程度的放大中国稀缺的医疗资源。
导医通医生版，是为医生提供的专属工作平台。通过导医通平台医生可以利用碎片时间为患者提供在线问诊等服务。
【医生工作台】医生的线上移动工作室，一站式医患服务平台。
【在线问诊】认证并开通服务后，可为患者提供图文问诊、视频问诊等服务。
【自主定价】自定义服务价格，自由安排时间，有效利用碎片时间为患者服务。
【在线开方】多点执业备案医生在线开电子处方，患者凭处方在线购药。
温馨提醒：医生版APP为医生专用，如您是患者，请搜索下载 “导医通”。
Hide
Show More...
应用介绍：
导医通志在患者、医院、医生之间建立起一个一站式的移动医疗医患服务平台。用移动互联网的创新服务模式
来革新传统医疗的服务模式，优化医疗服务流程，通过移动互联网来大程度的放大中国稀缺的医疗资源。
导医通医生版，是为医生提供的专属工作平台。通过导医通平台医生可以利用碎片时间为患者提供在线问诊等服务。
【医生工作台】医生的线上移动工作室，一站式医患服务平台。
【在线问诊】认证并开通服务后，可为患者提供图文问诊、视频问诊等服务。
【自主定价】自定义服务价格，自由安排时间，有效利用碎片时间为患者服务。
【在线开方】多点执业备案医生在线开电子处方，患者凭处方在线购药。
温馨提醒：医生版APP为医生专用，如您是患者，请搜索下载 “导医通”。
Screenshots
N/A FAQ
-
Is 导医通医生版 free?
Yes, 导医通医生版 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 导医通医生版 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 导医通医生版 cost?
导医通医生版 is free.
-
What is 导医通医生版 revenue?
To get estimated revenue of 导医通医生版 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Türkiye yet.
Ratings History
N/A Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
导医通医生版 Installs
Last 30 days
导医通医生版 Revenue
Last 30 daysN/A Revenue and Downloads
Gain valuable insights into 导医通医生版 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Daoyitong.com
- Languages
- Chinese
- Recent release
- 1.9.1 (1 month ago )
- Released on
- Jul 31, 2018 (6 years ago )
- Also available in
- South Korea, Türkiye, Thailand, Sweden, Saudi Arabia, Romania, Philippines, Netherlands, Kuwait, Belarus, Italy, India, Indonesia, Hungary, Hong Kong SAR China, Colombia, Chile, Switzerland
- Last Updated
- 5 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.